Delivery Order SPE2DB20D1100-SPE2DB24FA7G5
Award Date 3/14/24
Potential Completion Date 3/15/24
Potential Value $3.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The $15,436.60 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer for Amerisourcebergen. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 30, 2024. This award is likely part of a larger indefinite...
- This federal contract award, valued at $3,620.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4564222395 - Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with an ultimate completion date of April 10, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $2,444.22 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, acting as the prime contractor, will provide the Department of Defense with fluticasone propionate HFA 220 mcg 12 gm...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product fluticasone prop hfa 44 mcg 10.6 gm. The $2,110.33 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,364.15 firm fixed price contract is for the supply of 4564605553 - Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,200.66 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA7G5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The $3,728.88 firm fixed price delivery order has a performance period through March 15, 2024. Amerisourcebergen Drug Corp previously received an indefinite delivery contract (IDC) from DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.
Generated 6/13/24, 9:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 3/14/24 |